BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ito M, Kunii Y, Horikoshi S, Miura I, Itagaki S, Shiga T, Yabe H. Young patient with treatment-resistant schizophrenia drastically improved by combination of clozapine and maintenance electroconvulsive therapy: a case report. Int Med Case Rep J 2019;12:185-8. [PMID: 31297000 DOI: 10.2147/IMCRJ.S198124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Purohith AN, Chatorikar SA, Praharaj SK, Bhandary RP, Sharma PSVN. “Efficacy and Safety of Maintenance Electroconvulsive Therapy (M-ECT) in Treatment-Resistant Schizophrenia: A Case Series”. Asian Journal of Psychiatry 2022. [DOI: 10.1016/j.ajp.2022.103132] [Reference Citation Analysis]
2 Dragoi AM, Radulescu I, Năsui BA, Pop AL, Varlas VN, Trifu S. Clozapine: An Updated Overview of Pharmacogenetic Biomarkers, Risks, and Safety-Particularities in the Context of COVID-19. Brain Sci 2020;10:E840. [PMID: 33187329 DOI: 10.3390/brainsci10110840] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
3 Kellner CH, Obbels J, Sienaert P. When to consider electroconvulsive therapy (ECT). Acta Psychiatr Scand 2020;141:304-15. [PMID: 31774547 DOI: 10.1111/acps.13134] [Cited by in Crossref: 41] [Cited by in F6Publishing: 30] [Article Influence: 20.5] [Reference Citation Analysis]